Compare HROW & DAKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HROW | DAKT |
|---|---|---|
| Founded | 1998 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Office Equipment/Supplies/Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 846.9M |
| IPO Year | 2008 | 1996 |
| Metric | HROW | DAKT |
|---|---|---|
| Price | $28.30 | $19.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 2 |
| Target Price | ★ $62.63 | $33.67 |
| AVG Volume (30 Days) | ★ 635.5K | 459.9K |
| Earning Date | 11-09-2026 | 12-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 71.43 | ★ 538.10 |
| EPS | N/A | ★ 0.40 |
| Revenue | N/A | ★ $608,932,000.00 |
| Revenue This Year | $28.13 | $6.68 |
| Revenue Next Year | $56.02 | $7.97 |
| P/E Ratio | ★ N/A | $49.88 |
| Revenue Growth | N/A | ★ 6.89 |
| 52 Week Low | $25.76 | $16.77 |
| 52 Week High | $54.98 | $28.27 |
| Indicator | HROW | DAKT |
|---|---|---|
| Relative Strength Index (RSI) | 47.12 | 52.49 |
| Support Level | $27.75 | $18.92 |
| Resistance Level | $30.28 | $20.74 |
| Average True Range (ATR) | 1.66 | 0.74 |
| MACD | 0.31 | -0.03 |
| Stochastic Oscillator | 35.42 | 33.06 |
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.
Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.